Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/2637
Title: | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Authors: | Momir Mikov Maja Đanić Nebojša Pavlović Bojan Stanimirov Svetlana Goločorbin-Kon Karmen Stankov Hani Al-Salami |
Issue Date: | 1-Jun-2018 | Journal: | European Journal of Drug Metabolism and Pharmacokinetics | Abstract: | © 2017, Springer International Publishing AG. A major advancement in therapy of type 1 diabetes mellitus (T1DM) is the discovery of new treatment which avoids and even replaces the absolute requirement for injected insulin. The need for multiple drug therapy of comorbidities associated with T1DM increases demand for developing novel therapeutic alternatives with new mechanisms of actions. Compared to other sulphonylurea drugs used in the treatment of type 2 diabetes mellitus, gliclazide exhibits a pleiotropic action outside pancreatic β cells, the so-called extrapancreatic effects, such as antiinflammatory and cellular protective effects, which might be beneficial in the treatment of T1DM. Results from in vivo experiments confirmed the positive effects of gliclazide in T1DM that are even more pronounced when combined with other hypoglycaemic agents such as probiotics and bile acids. Even though the exact mechanism of interaction at the molecular level is still unknown, there is a clear synergistic effect between gliclazide, bile acids and probiotics illustrated by the reduction of blood glucose levels and improvement of diabetic complications. Therefore, the manipulation of bile acid pool and intestinal microbiota composition in combination with old drug gliclazide could be a novel therapeutic approach for patients with T1DM. | URI: | https://open.uns.ac.rs/handle/123456789/2637 | ISSN: | 3787966 | DOI: | 10.1007/s13318-017-0441-y |
Appears in Collections: | MDF Publikacije/Publications |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Potential applications of gliclazide in treating type 1 diabetes mellitus - formulation with bile acids and probiotics.pdf | 681.91 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
22
checked on May 10, 2024
Page view(s)
49
Last Week
7
7
Last month
6
6
checked on May 10, 2024
Download(s)
111
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.